PT Kalbe Farma Tbk. (PTKFF)

Market Cap	3.49B
Revenue (ttm)	2.03B
Net Income (ttm)	201.31M
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	17.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,500
Average Volume	4,133
Open	0.0751
Previous Close	0.0650
Day's Range	0.0751 - 0.0751
52-Week Range	0.0649 - 0.1135
Beta	0.16
RSI	38.77
Earnings Date	Mar 27, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the comp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial numbers in IDR